Marlies Reinders
Marlies E. J. Reinders (born 1973) is a Dutch internist-nephrologist and academic administrator. Since 1 October 2024, she has worked as dean of the Faculty of Medicine at Leiden University and as a member of the executive board of Leiden University Medical Center (LUMC). She was appointed professor of Internal Medicine in 2017 and previously worked as head of Nephrology and Kidney Transplantation at Erasmus MC and chair of the Erasmus MC Transplant Institute.[1][2]
Education and career
Reinders studied medicine at the University of Groningen. During her doctoral research, she worked in Boston at Boston Children's Hospital and Harvard Medical School in the field of kidney transplantation. She received her PhD from Leiden University with a thesis on the relationship between angiogenesis and immunity in transplantation.[3] Reinders later worked as an internist-nephrologist at Leiden University Medical Center from 2009 to 2020. In 2020, she moved to Erasmus MC, where she became head of Nephrology and Kidney Transplantation; from 2023 to 2024, she also chaired the Erasmus MC Transplant Institute. In 2024, Leiden University and LUMC announced her appointment as dean of the Faculty of Medicine and a member of the LUMC Board of Directors.[4][2]
Research and academic work
Her research has focused on clinical kidney transplantation and transplantation medicine.[5] She was a co-investigator in the Dutch RECOVAC consortium, which studied the impact of COVID-19 vaccination and infection on patients with kidney disease.[6][7] She has also worked on educational innovation, including the development of the Massive Open Online Course (MOOC) Clinical Kidney, Pancreas and Islet Transplantation, launched in 2016.[8][9]
Professional service
Reinders worked as chair of the Dutch Transplant Society from 2016 to 2021 and has been a member of the Eurotransplant Board. She has also worked on education committees of the European Society for Organ Transplantation (ESOT) and The Transplantation Society (TSS).[10] In 2017, she was among a group of Dutch transplantation specialists who publicly argued for a new organ donation law in the Netherlands.[11]
Reinders serves on the supervisory boards of Medical Delta and RegMed XB.[12][13] In 2026, she commented on renewed Novo Nordisk Foundation funding for LUMC's participation in the reNEW regenerative medicine consortium.[14]
References
- ↑ "Marlies Reinders new Dean of Faculty of Medicine and member of LUMC Board of Directors". Leiden University. 2024-06-21. Retrieved 2026-03-07.
- 1 2 Redactie, Skipr (2024-06-21). "LUMC benoemt nieuw lid raad van bestuur". Skipr (in Dutch). Retrieved 2026-03-24.
- ↑ "Briscoe Lab". Transplant Research Program. Retrieved 2026-03-24.
- ↑ "Marlies Reinders • ESOT". Retrieved 2026-03-07.
- ↑ "Marlies Reinders". European Society for Organ Transplantation. Retrieved 7 March 2026.
- ↑ "Coronavaccin lijkt werkzaam bij groot deel van de nierpatiënten, maar voorzichtigheid blijft geboden". Nierstichting (in Dutch). 2021. Retrieved 7 March 2026.
- ↑ "RECOVAC ontdekt steeds meer over vaccinatie bij nierpatiënten". Nierstichting (in Dutch). 15 September 2022. Retrieved 7 March 2026.
- ↑ "LUMC offers free online course on transplantation". Leiden University. 7 January 2016. Retrieved 7 March 2026.
- ↑ "MOOCs are more than online education". Leiden University. 18 April 2017. Retrieved 7 March 2026.
- ↑ "Marlies Reinders". Leiden University. Retrieved 7 March 2026.
- ↑ "Deskundigen pleiten voor nieuwe orgaandonatiewet". www.medischcontact.nl (in Dutch). 2017-05-10. Retrieved 2026-03-24.
- ↑ "Board, Supervisory Board and Team". Medical Delta. Retrieved 2026-03-24.
- ↑ "Partner council | RegMed XB". regmedxb.com. Retrieved 2026-03-24.
- ↑ IO+, Team (2026-03-05). "Novo Nordisk invests €150M in Dutch stem cell research". IO+. Retrieved 2026-03-24.